Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of Microbiology Business to Astorg

"Axinn advised Thermo Fisher Scientific Inc. on the completed sale of its microbiology business to Astorg for approximately $1.075 billion. The business supplies antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing."

Axinn advised Thermo Fisher Scientific Inc. on the completed sale of its microbiology business to Astorg, a leading pan‑European private equity firm. The transaction was completed for approximately $1.075 billion and transfers Thermo Fisher’s microbiology business to Astorg. The business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing. Axinn represented Thermo Fisher Scientific Inc. with a team composed by: partners James Hunsberger and Mark Alexander, and associates Megan Walden, Taylor Aiello and Leandra Ipiña.

Menu

Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of Microbiology Business to Astorg

Read the full story

Menu

Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of Microbiology Business to Astorg

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads